Status:
COMPLETED
Efficacy of PRADO Heart Failure in Occitania
Lead Sponsor:
University Hospital, Montpellier
Conditions:
Heart Failure
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Patients with heart failure (IC), after hospitalization, have a marked fragility: in France, in the first year, 29% die and 45% are readmitted to IC. Interventions improving the coordination of care p...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- 18 years or older
- Hospitalization for heart failure
- Subject living at home
- Informed consent
- Exclusion criteria:
- discharge to a rehabilitation clinic or to medical home for elderly people
- subject without health insurance
- terminal kidney failure
- programmed heart surgery
- waiting for heart transplantation
- psycho-cognitive impairment
- patient not autonomous for mobility at home
- supportive care
- planned move to medical home for elderly people in the coming 6 months
- no fluent french
- not able to provide informed consent
- participating to other study
Exclusion
Key Trial Info
Start Date :
May 4 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 9 2022
Estimated Enrollment :
404 Patients enrolled
Trial Details
Trial ID
NCT03396081
Start Date
May 4 2018
End Date
May 9 2022
Last Update
September 30 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Montpellier
Montpellier, France, 34295